Trial Profile
Phase I trial of STI 6991 for COVID-2019 infection (Prevention) in USA
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 01 Apr 2020
Price :
$35
*
At a glance
- Drugs STI 6991 (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- Sponsors Sorrento Therapeutics
- 01 Apr 2020 New trial record
- 25 Mar 2020 According to Sorrento Therapeutics media release, the company aims to start enrolling in a human clinical trial as early as mid-year 2020